Retinoic acid receptor antagonist compounds and methods
申请人:Ligand Pharmaceuticals Incorporated
公开号:US05998654A1
公开(公告)日:1999-12-07
Trienoic compounds having activity as antagonists for retinoic acid receptors are provided. Also provided are pharmaceutical compositions incorporating such compounds and methods for their therapeutic use.